Company / Capital Returned to Shareholders per Share
Merck & Co. Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$5.21
FY2025
5-year range
$2.76 / $5.21
FY2021-FY2025
Trend
+44.7%
vs FY2024
Sector context
#7 of 51
Health Care
What the data says
Merck & Co.'s capital returned to shareholders per share of $5.21 is higher than 86% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders per Share has increased for 3 consecutive years, from $2.76 in FY2022 to $5.21 in FY2025.
Based on SEC 10-K filings.
5.21 in FY2025 with a 5-year CAGR of +13.2%. Top quartile in the Health Care sector.
Improved from $3.46 to $5.21 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +23.6%
- 5-Year CAGR
- +13.2%
- 10-Year CAGR
- -
Sector benchmark
+90.3% above sector average
Key checks
Key Insights
- Merck & Co.'s capital returned to shareholders per share has grown for 3 consecutive years.
- In FY2025, capital returned to shareholders per share increased 44.7% year-over-year.
- Ranks #7 out of 51 companies in the Health Care sector.
- Lowest capital returned to shareholders per share in the period was in FY2022.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.21 | +44.7% |
| FY2024 | $3.60 | +3.9% |
| FY2023 | $3.46 | +25.5% |
| FY2022 | $2.76 | -4.4% |
| FY2021 | $2.89 | +3.2% |
| FY2020 | $2.80 | -26.6% |
| FY2019 | $3.81 | -25.5% |
| FY2018 | $5.12 | +58.4% |
| FY2017 | $3.23 | +10.6% |
| FY2016 | $2.92 | -5.9% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026